Literature DB >> 18193158

Evolutionary rate heterogeneity of Alu repeats upstream of the APOA5 gene: do they regulate APOA5 expression?

Edward A Ruiz-Narváez1,2, Hannia Campos3.   

Abstract

The APOA5 gene, located in the APOA1/C3/A4/A5 gene cluster, is a key regulator of triglyceride metabolism. ApoAV plasma concentration is much lower as compared to other apolipoproteins such as apoCIII and apoAI. This is due in part to the fact that the APOC3-enhancer, which up-regulates transcription of the APOA1, APOC3, and APOA4 genes, does not increase expression of the APOA5 gene. We postulated that intervening Alu repeats in the APOA5-APOA4 intergenic region gene might be blocking action of the APOC3-enhancer over the APOA5-promoter. To search for evidence of functional significance of the intervening Alu sequences, we estimated nucleotide substitution rates of 21 pairs of Alu elements in the APOA5-APOA4 intergenic region by comparing published sequences of human and chimpanzee. Also, we scanned the intergenic region for the presence of binding sites of the insulator protein CTCF. Seven out of the nine found CTCF binding sites were located in the first half of the intergenic region. Five out of those seven CTCF binding sites were placed inside Alu elements. Based on their substitution rates, we found two clearly defined groups of Alu sequences: a slow-evolving group (mean 0.98 +/- 0.18) and a fast-evolving group (mean 2.74 +/- 0.54). Alu repeats with lower substitution rate tended to be located up to 14-kb upstream of the APOA5 gene, to belong to the oldest J-family and to have an opposite orientation to the APOA5 gene. Some Alu sequences may have functional relevance on the regulation of the APOA5-gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193158     DOI: 10.1007/s10038-008-0245-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  36 in total

1.  Negative regulation of the human epsilon-globin gene by transcriptional interference: role of an Alu repetitive element.

Authors:  J Wu; G J Grindlay; P Bushel; L Mendelsohn; M Allan
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

2.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

Authors:  Philippa J Talmud; Emma Hawe; Steve Martin; Michael Olivier; George J Miller; Edward M Rubin; Len A Pennacchio; Steve E Humphries
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

3.  An Alu element from the K18 gene confers position-independent expression in transgenic mice.

Authors:  D A Willoughby; A Vilalta; R G Oshima
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

4.  Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.

Authors:  Annelise Genoux; Hélène Dehondt; Audrey Helleboid-Chapman; Christian Duhem; Dean W Hum; Geneviève Martin; Len A Pennacchio; Bart Staels; Jamila Fruchart-Najib; Jean-Charles Fruchart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-24       Impact factor: 8.311

Review 5.  Transcriptional regulation of the genes involved in lipoprotein transport. The role of proximal promoters and long-range regulatory elements and factors in apolipoprotein gene regulation.

Authors:  D Kardassis; M Laccotripe; I Talianidis; V Zannis
Journal:  Hypertension       Date:  1996-04       Impact factor: 10.190

6.  The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.

Authors:  Xavier Prieur; Herve Coste; Joan C Rodriguez
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

7.  The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.

Authors:  Peter J O'Brien; William E Alborn; John H Sloan; Maverick Ulmer; Amechand Boodhoo; Michael D Knierman; Albert E Schultze; Robert J Konrad
Journal:  Clin Chem       Date:  2004-11-04       Impact factor: 8.327

8.  Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level.

Authors:  I Sakurabayashi; Y Saito; T Kita; Y Matsuzawa; Y Goto
Journal:  Clin Chim Acta       Date:  2001-10       Impact factor: 3.786

9.  Apolipoproteins C-II and C-III in serum quantified by zone immunoelectrophoresis.

Authors:  W März; G Schenk; W Gross
Journal:  Clin Chem       Date:  1987-05       Impact factor: 8.327

10.  Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons.

Authors:  Qian-fei Wang; Xin Liu; Jeff O'Connell; Ze Peng; Ronald M Krauss; David L Rainwater; John L VandeBerg; Edward M Rubin; Jan-Fang Cheng; Len A Pennacchio
Journal:  Hum Mol Genet       Date:  2004-03-25       Impact factor: 6.150

View more
  3 in total

1.  The clustering of CpG islands may constitute an important determinant of the 3D organization of interphase chromosomes.

Authors:  Ekaterina S Gushchanskaya; Artem V Artemov; Sergey V Ulyanov; Maria D Logacheva; Aleksey A Penin; Elena S Kotova; Sergey B Akopov; Lev G Nikolaev; Olga V Iarovaia; Eugene D Sverdlov; Alexey A Gavrilov; Sergey V Razin
Journal:  Epigenetics       Date:  2014-04-15       Impact factor: 4.528

2.  Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity.

Authors:  L G Nikolaev; S B Akopov; D A Didych; E D Sverdlov
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

3.  The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells.

Authors:  Mireia Jordà; Anna Díez-Villanueva; Izaskun Mallona; Berta Martín; Sergi Lois; Víctor Barrera; Manel Esteller; Tanya Vavouri; Miguel A Peinado
Journal:  Genome Res       Date:  2016-12-20       Impact factor: 9.043

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.